[go: up one dir, main page]

MX2012005441A - Uso de composiciones que contienen luteina para mejorar ciertos aspectos de la memoria. - Google Patents

Uso de composiciones que contienen luteina para mejorar ciertos aspectos de la memoria.

Info

Publication number
MX2012005441A
MX2012005441A MX2012005441A MX2012005441A MX2012005441A MX 2012005441 A MX2012005441 A MX 2012005441A MX 2012005441 A MX2012005441 A MX 2012005441A MX 2012005441 A MX2012005441 A MX 2012005441A MX 2012005441 A MX2012005441 A MX 2012005441A
Authority
MX
Mexico
Prior art keywords
memory
certain aspects
containing compositions
lutein
improve certain
Prior art date
Application number
MX2012005441A
Other languages
English (en)
Other versions
MX353505B (es
Inventor
Regina Goralczyk
Hasan Mohajeri
Annis Olivia Maynemechan
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of MX2012005441A publication Critical patent/MX2012005441A/es
Publication of MX353505B publication Critical patent/MX353505B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03Organic compounds
    • A23L29/035Organic compounds containing oxygen as heteroatom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/02Halogenated hydrocarbons
    • A61K31/025Halogenated hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Esta invención se relaciona a un método de incremento de un aspecto de la memoria en un individuo saludable, caracterizado porque el aspecto de memoria se selecciona de un grupo que consiste de: memoria asociativa, memoria espacial y memoria bajo estrés que comprende: administrar una composición que consiste de: a) una cantidad efectiva de ya sea luteína o una combinación de luteína y zeaxantina; y b) un portador apropiado; y observar el incremento de la memoria asociativa, memoria espacial o memoria bajo estrés.
MX2012005441A 2009-11-09 2010-11-05 Uso de composiciones que contienen luteina para mejorar ciertos aspectos de la memoria. MX353505B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27282309P 2009-11-09 2009-11-09
PCT/EP2010/066949 WO2011054944A1 (en) 2009-11-09 2010-11-05 Use of lutein containing compositions to improve certain aspects of memory

Publications (2)

Publication Number Publication Date
MX2012005441A true MX2012005441A (es) 2012-07-03
MX353505B MX353505B (es) 2018-01-17

Family

ID=43304680

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012005441A MX353505B (es) 2009-11-09 2010-11-05 Uso de composiciones que contienen luteina para mejorar ciertos aspectos de la memoria.

Country Status (8)

Country Link
US (1) US20120232162A1 (es)
EP (1) EP2498765A1 (es)
JP (1) JP6163682B2 (es)
KR (1) KR101766932B1 (es)
CN (2) CN102612364A (es)
BR (1) BR112012010964A2 (es)
MX (1) MX353505B (es)
WO (1) WO2011054944A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1214512A1 (zh) * 2013-05-24 2016-07-29 株式会社明治 运动功能提高剂
EP3265069B1 (en) 2015-03-02 2025-06-11 OmniActive Health Technologies Limited Method for stress management and overall health status improvement and compositions used therein
EP3632418A4 (en) * 2017-06-01 2021-02-24 Santen Pharmaceutical Co., Ltd. COMPOSITION OF LUTEIN, OR SALT THEREOF, AND A PROCESSED PRODUCT OF A PLANT OF THE GENUS T, PREVENTING AND / OR IMPROVING BRAIN DYSFUNCTION
NL2019436B1 (en) 2017-08-23 2019-03-07 Newtricious Bv Composition comprising a xantophyll and an omega-3 fatty acid and method of use thereof
KR20210045443A (ko) 2018-09-28 2021-04-26 가부시기가이샤오오쓰까세이야꾸고오죠오 아카보즈 또는 스타키오스를 포함하는 포유동물 세포 보존용 액
CN111838321A (zh) * 2020-08-18 2020-10-30 青岛大学 一种含叶黄素和益生元的老年营养包及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07224029A (ja) * 1994-02-09 1995-08-22 Sogo Biyou Ikagaku Kenkyusho:Kk 抗酸化活性をもつカロチノイド含有エキス、その製造法及び抗酸化剤
US6572899B1 (en) * 2002-07-03 2003-06-03 Vitacost.Com, Inc. Memory loss treatment formulation
US20060205826A1 (en) 2005-03-09 2006-09-14 Romero Francisco J Method of using carotenoids in the prevention of cognitive decline and for other neuroprotection functions
WO2006116755A2 (en) * 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
US20100076091A1 (en) * 2007-02-14 2010-03-25 Tohoku University Composition and method for suppressing lipooxidation of erythrocyte

Also Published As

Publication number Publication date
JP6163682B2 (ja) 2017-07-19
US20120232162A1 (en) 2012-09-13
WO2011054944A1 (en) 2011-05-12
CN107050000A (zh) 2017-08-18
EP2498765A1 (en) 2012-09-19
JP2013510129A (ja) 2013-03-21
MX353505B (es) 2018-01-17
BR112012010964A2 (pt) 2018-09-11
KR20120115253A (ko) 2012-10-17
CN102612364A (zh) 2012-07-25
KR101766932B1 (ko) 2017-08-09

Similar Documents

Publication Publication Date Title
TN2009000521A1 (en) Rnai inhibition of alpha-enac expression
WO2013122932A3 (en) Topical use of a skin-commensal prebiotic agent and compositions containing the same
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
MY148496A (en) Dpp iv inhibitor formulations
MY159630A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
UA111065C2 (uk) Композиції норибогаїну
WO2008085221A3 (en) Therapeutic use of cd31 expressing cells
MX2013004061A (es) Analogos de ciclosporina.
MX2012005441A (es) Uso de composiciones que contienen luteina para mejorar ciertos aspectos de la memoria.
PH12013502215A1 (en) Beautiful-skin-promoting agent and use thereof
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
EA201101214A1 (ru) Полиеновые противогрибковые композиции
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
PH12017502404A1 (en) Musk compositions and methods of use thereof
MX2013004062A (es) Analogos de ciclosporina.
MX2012005394A (es) Composiciones y metodos para mejorar las pestañas.
MX2010001693A (es) Composicion pulverizable que contiene extracto de hojas de parra rojas.
PH12015501251A1 (en) Compositions and methods for treating dental caries
TW201129394A (en) Composition for inhibiting melanogenesis and use thereof
WO2009158387A3 (en) Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption
PH12012502253A1 (en) Oral care compositions and methods
WO2011018477A3 (en) Carnosol for hair and skin care
UA97521C2 (ru) и-РНК-АГЕНТ, КОТОРЫЙ ОПОСРЕДУЕТ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC
UA96034C2 (en) Use of 4,3'-spiro[(2-amino-3-cyano-4,5-dihydropyrano[3,2-c]chromene-5-one-5-methyl-2'-oxyindole] as cerebroprotective agent

Legal Events

Date Code Title Description
FG Grant or registration